Zimbabwe: Natpharm Gets Consignment of TB Drugs From MSF
[The Herald] Herald Reporter (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 28, 2021 Category: Infectious Diseases Source Type: news

South Africa: Important TB Drug As Effective at Lower Dose, Study Finds
[spotlight] The treatment of drug-resistant forms of tuberculosis (DR-TB) has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year. Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half and involve taking many different pills every day. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 26, 2021 Category: Infectious Diseases Source Type: news

Africa: WHO Position Statement On Innovative Clinical Trial Designs for Development of New TB Treatments
[WHO] The World Health Organization is publishing a position statement on Innovative Clinical Trial Designs for Development of New TB Treatments. This document aims to support TB regimen development by highlighting key clinical trial characteristics to help advance novel therapies. It summarises key innovations in TB clinical trial designs, ranging from pharmacokinetic-pharmacodynamic (PK-PD) modelling and new advances in biomarker development to the value of novel clinical trial design methodologies and post-li (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 26, 2021 Category: Infectious Diseases Source Type: news

Africa: Investing in New TB Vaccines - It's Time to End the Century-Long Wait!
[WHO] Dear colleagues, partners and friends, (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 26, 2021 Category: Infectious Diseases Source Type: news

Cell-analysis technique could combat tuberculosis
(Cornell University) Researchers at Cornell have developed a way to analyze how individual immune cells react to the bacteria that cause tuberculosis. It could pave the way for new vaccine strategies and provide insights into fighting other infectious diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

How COVID-19 Long Haulers Could Change the U.S. Disability Benefits System
When COVID-19 began spreading in the U.S. in March 2020, McKale Santin was working at a nursing home in Burlington, Vermont. She and her coworkers didn’t yet know how deadly the virus would become, but she remembers feeling nervous as the first patients got sick and she was asked to examine them with only a surgical mask, not the more protective N95 mask that she wore to test for conditions like tuberculosis. One day, a patient pulled down her own mask to sneeze while Santin was conducting a respiratory assessment. Soon after, the woman became one of Vermont’s first people to die from COVID-19—and Santin...
Source: TIME: Health - July 20, 2021 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 feature Source Type: news

Resistant TB: Adjustments to BPaL Regimen Reduce AEs, Not Efficacy Resistant TB: Adjustments to BPaL Regimen Reduce AEs, Not Efficacy
High success rates in tuberculosis treatment remain after lowering linezolid dose and duration to reduce toxic effects.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 19, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

South Africa: Scientists Develop New Method of Diagnosing TB From Skin
[UCT] A team of scientists, including those from the University of Cape Town (UCT), have developed a new diagnostic methodology enabling a non-invasive, fast and highly accurate way of detecting tuberculosis (TB). (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 16, 2021 Category: Infectious Diseases Source Type: news

South Africa: Could Community Health Workers Be the Answer to Reducing Tuberculosis Stigma?
[spotlight] Thandeka* is walking with her backpack through the streets of Khayelitsha. She is an uNompilo - a community health worker. She is describing a typical experience of one of the people she is helping with Tuberculosis (TB). (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 16, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Health Experts Seek More Effective, Affordable Vaccines to Tackle Tuberculosis
[Premium Times] Global health experts seek improvement of the 100-year-old BCG vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 16, 2021 Category: African Health Source Type: news

Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
(Radboud University Medical Center) To advance anti-tuberculosis (TB) science and enable theprogression of new, safe, and affordable treatment solutions for TB patients worldwide, a newconsortium of 30 partners from 13 countries has officially launched. The 7-year, € 185 millionproject called UNITE4TB, aims to accelerate and improve the clinical evaluation of combinations ofexisting and novel drugs, with the goal of developing new and highly active TB treatment regimensfor drug-resistant and -sensitive TB. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development
(Critical Path Institute (C-Path)) To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. The 7-year, € 185 million project called UNITE4TB, aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs, with the goal of developing new and highly active TB treatment regimens for drug-resistant and -sensitive TB. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Africa: Active TB Drug Safety Monitoring and Management (ADSM) Global Database - Outcome of the Assessment and Future of Data Reporting
[WHO] A global database set up by WHO's Global Tuberculosis Programme in collaboration with the Special Programme for Research and Training in Tropical Diseases (TDR) has been collating data on Active TB Drug Safety Monitoring and Management (aDSM) since 2016, to monitor the safety of patients who receive MDR-TB treatment with new medicines (e.g. bedaquiline, delamanid), repurposed medicines (e.g. linezolid, clofazimine) or new regimens, which don't have a well-established safety profile. The aDSM framework has (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 12, 2021 Category: Infectious Diseases Source Type: news

Africa: New WHO Recommendations Issued to Improve Access to Rapid Molecular Tests for the Detection of TB and Drug-Resistant TB
[WHO] The World Health Organization (WHO) has issued an update to its consolidated guidelines on the detection of TB and drug-resistant TB. The guidelines are accompanied by an operational handbook to facilitate rapid implementation and roll out of rapid molecular tests by national TB programmes, ministries of health and technical partners. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 12, 2021 Category: Infectious Diseases Source Type: news

Progress towards new treatments for tuberculosis
(Walter and Eliza Hall Institute) Boosting the body's own disease-fighting immune pathway could provide answers in the desperate search for new treatments for tuberculosis. Tuberculosis still represents an enormous global disease burden and is one of the top 10 causes of death worldwide.The study uncovered how cells infected with tuberculosis bacteria can die, and that using new medicines to enhance particular forms of cell death decreased the severity of the disease in a preclinical model. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2021 Category: International Medicine & Public Health Source Type: news

Suicide attempt with isoniazid in adolescents receiving tuberculous prophylaxis: three cases - Polat E, Şenel S.
An overdose of isoniazid (INH) is potentially fatal and attempts at suicide are very rare in children. Three patients aged 14-17  years who were receiving INH for tuberculosis prophylaxis were admitted to the emergency department with generalised tonic-clo... (Source: SafetyLit)
Source: SafetyLit - July 9, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats
NEW BRUNSWICK, N.J., July 9, 2021 – Johnson & Johnson (the Company) today announced the launch of the J&J Centers for Global Health Discovery (J&J Centers), a new, global network of unique research partnerships that will leverage the institutional strengths of Johnson & Johnson and leading academic institutions to accelerate discovery research to address the world’s most pressing global health challenges. The first J&J Satellite Center for Global Health Discovery (Satellite Center) was launched at the London School of Hygiene & Tropical Medicine (LSHTM) at an event co-hosted by Johnson &...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Nigeria: Bauchi Govt Targets 1.5m Children for Malaria Treatment - Official
[Daily Trust] Bauchi State Agency for the Control of HIV/AIDS, Malaria, Leprosy and Tuberculosis (BACATMA), says it has targeted 1.5 million children for the 2021 Seasonal Malaria Chemoprevention (SMC) campaign. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 9, 2021 Category: African Health Source Type: news

WHO guidelines now include Roche ’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis
Basel, 09 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® MTB and cobas® MTB-RIF/INH tests for use on the cobas® 6800/8800 Systems are included as part of the updated World Health Organization (WHO) policy guidelines on nucleic acid amplification tests (NAATs) to detect tuberculosis (TB) and drug-resistant TB. The new guidance expands the number of ra pid molecular tests available to national TB programmes in high-burden countries, enabling multi-partner diagnostic approaches that can benefit patients and communities. (Source: Roche Investor Update)
Source: Roche Investor Update - July 9, 2021 Category: Pharmaceuticals Source Type: news

WHO guidelines now include Roche ’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis
Basel, 09 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® MTB and cobas® MTB-RIF/INH tests for use on the cobas® 6800/8800 Systems are included as part of the updated World Health Organization (WHO) policy guidelines on nucleic acid amplification tests (NAATs) to detect tuberculosis (TB) and drug-resistant TB. The new guidance expands the number of ra pid molecular tests available to national TB programmes in high-burden countries, enabling multi-partner diagnostic approaches that can benefit patients and communities. (Source: Roche Media News)
Source: Roche Media News - July 9, 2021 Category: Pharmaceuticals Source Type: news

TB Risk Increased in People With Mental Illness TB Risk Increased in People With Mental Illness
Individuals with depression or schizophrenia appear to be at increased risk for tuberculosis, according to published studies.Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 8, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Tuberculosis (TB) action plan for England
The UK Health Security Agency (UKHSA) working with NHS England launched a 5 year action plan to drive down tuberculosis (TB) cases in England The (tuberculosis) action plan will focus on the needs of those affected by and services whilst recognising the impact and learning of the coronavirus (COVID-19) pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 7, 2021 Category: Consumer Health News Source Type: news

Launch of Cochrane Cameroon celebrated
The launch of Cochrane Cameroon was officially celebrated on 30 June from its base at theH ôpital Central de Yaoundé.At the launch Cochrane Cameroon highlighted its commitment to promoting evidence-based healthcare policy and practice; translation of research to policy and practice; advocating for evidence to promote access and equity to healthcare; effective collaboration, and, strengthening capacity for conducting and using systematic reviews." Cochrane Cameroon will play an important role in developing a critical mass of those who understand the role of evidence in improving healthcare, " sai...
Source: Cochrane News and Events - July 7, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Namibia: Living With Pott's Disease
[Namibian] WHILE the world is battling the deadly Covid-19 pandemic, 36-year-old Joseph Haikali is fighting a rare disease that causes his joints and knees to continuously keep swelling. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 7, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Lagos Is Nigeria's Tuberculosis Epicentre - Official
[Premium Times] Nigeria remains one of the 30 countries globally with the highest burden of the disease, while it also ranks first in Africa in the number of undetected cases. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 7, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Lagos Is Country's Tuberculosis Epicentre - Official
[Premium Times] Nigeria remains one of the 30 countries globally with the highest burden of the disease, while it also ranks first in Africa in the number of undetected cases. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 7, 2021 Category: African Health Source Type: news

New Regional Advisors Will Guide Frontline Health Workers Coalition ’s Policy and Advocacy Work
July 02, 2021This week the Frontline Health Workers Coalition welcomed four new regional advisors from low- and middle-income countries to its steering committee, where they will help guide the coalition’s health workforce policy and advocacy work over the next year. IntraHealth International serves as the secretariat for the coalition.“We are working to address longstandingpower imbalances in the global health arena, and reflecting on ways to more comprehensively address health workforce needs,” says David Bryden, director of the Coalition.“We do not simply want to speak on behalf of health workers...
Source: IntraHealth International - July 2, 2021 Category: International Medicine & Public Health Authors: kseaton Tags: Health Workers Source Type: news

East Africa: How Covid-19 Measures Have Affected Food Safety in the Region
[The Conversation Africa] Foodborne diseases are thought to impose a health burden on society comparable to the "big three": malaria, HIV/AIDs and tuberculosis. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 2, 2021 Category: African Health Source Type: news

Africa: WHO and Global Fund Sign Cooperation Agreement to Scale Up HIV, TB and Malaria Interventions and Strengthen Health Systems
[WHO] The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria signed a cooperation and financing agreement to implement 10 strategic initiatives to accelerate the end of AIDS, tuberculosis and malaria as epidemics and strengthen systems for health. This new agreement, which will cover the 2021-2023 implementation period, aims to address some of the persistent challenges that impede progress against the three diseases and protect hard-won gains from new pandemics like COVID-19. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 1, 2021 Category: Infectious Diseases Source Type: news

Infographic: TB Vaccines in the Pipeline Take Varied Approaches
More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by... (Source: The Scientist)
Source: The Scientist - July 1, 2021 Category: Science Tags: Infographics Magazine Issue Source Type: news

Tuberculosis: The Forgotten Pandemic
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon. (Source: The Scientist)
Source: The Scientist - July 1, 2021 Category: Science Tags: Features Magazine Issue Source Type: news

New COVID-19 testing equipment deployed in Tonga
By External SourceTonga, Jun 30 2021 (IPS-Partners) Last week, the Tonga Laboratory Services completed the installation of a 4 module GeneXpert testing equipment used for diagnosis of COVID-19 infection and to increase SARS-coV-2 testing capacity. Prior to the COVID-19 pandemic, each Pacific Island Country and Territory (PICT) had one or two GeneXpert equipment for diagnosis of tuberculosis (TB) and sexually transmitted infections (STI), supported by Global Fund. The same equipment had been used for COVID-19 testing in the last 12 months. The progressive increase in demand for COVID-19 testing in PICTs over the past month...
Source: IPS Inter Press Service - Health - June 30, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Health Humanitarian Emergencies Pacific Community Climate Wire The Pacific Community (SPC) Source Type: news

South Africa: How Can We Improve Ventilation to Prevent Covid-19 and TB?
[spotlight] Ventilation plays an important role in preventing the transmission of airborne disease but currently, ventilation standards for buildings are focused on preventing odours in spaces, instead of preventing disease transmission. Both Tuberculosis (TB) and COVID-19 can infect an individual via airborne transmission. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 30, 2021 Category: African Health Source Type: news

Zimbabwe: Zim Makes Progress On TB
[The Herald] Health Reporter (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2021 Category: Infectious Diseases Source Type: news

Hackensack Meridian CDI scientists discover new tuberculosis treatment pathway
(Hackensack Meridian Health) The compound TA-C is metabolized by TB bacteria - weakening the germ from within like a 'Trojan horse' attack (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Structural biology reveals new opportunities to combat tuberculosis
(European Molecular Biology Laboratory) EMBL Hamburg's Wilmanns and Kosinski groups have determined the detailed structure of a bacterial protein complex critical for tuberculosis infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 25, 2021 Category: Infectious Diseases Source Type: news

Africa: Gavi and the Global Fund Sign Groundbreaking Agreement With International Federation of Accountants to Support in-Country Financial Management
[Global Fund] Geneva -- Global health leaders Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria have joined forces with the International Federation of Accountants (IFAC) to contribute to, and support, the implementation of robust accounting practices in the public health sector and to improve overall financial management of donor funds by implementing countries. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 24, 2021 Category: Infectious Diseases Source Type: news

Global Herd Immunity Remains Out of Reach Because of Inequitable Vaccine Distribution – 99% of People in Poor Countries Are Unvaccinated
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - June 24, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Headlines Health Poverty & SDGs Source Type: news

Africa: WHO Releases New Global Lists of High-Burden Countries for TB, HIV-Associated TB and Drug-Resistant TB
[WHO] The World Health Organization (WHO) today released updated global lists of high burden countries for tuberculosis (TB), HIV-associated TB and multidrug/rifampicin-resistant TB (MDR/RR-TB). The new lists are for 2021-2025 and replace those previously used between 2016 and 2020. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 24, 2021 Category: Infectious Diseases Source Type: news

Africa: WHO High-Level Event Galvanizes Commitment and Action to Accelerate the Global Drive to Scale Up TB Prevention
[WHO] On 16 June, WHO convened a high-level event to shine the spotlight on the importance of TB prevention which urgently needs to be ramped up to reduce suffering and save lives from TB - one of the world's top infectious killers. The event, titled "A global drive to scale up TB prevention" comes 18 months before the deadline established by Heads of State at the United Nations High Level Meeting on TB in 2018, to achieve ambitious targets towards ending TB. It is also 18 months into the COVID-19 pandemic that (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 24, 2021 Category: Infectious Diseases Source Type: news

Announcing the re-annotation of RefSeq genome assemblies for E. coli and four other species!
We have re-annotated all RefSeq genomes for Escherichia coli, Mycobacterium tuberculosis, Bacillus subtilis, Acinetobacter pittii, and Campylobacter jejuni using the most recent release of PGAP. You will find that more genes now have gene symbols (e.g. recA). Your feedback indicated that the lack of symbols was an impediment to comparative analysis, so we hope that this improvement … Continue reading Announcing the re-annotation of RefSeq genome assemblies for E. coli and four other species! → (Source: NCBI Insights)
Source: NCBI Insights - June 23, 2021 Category: Databases & Libraries Authors: NCBI Staff Tags: What's New Genome annotation Genome assemblies NCBI Prokaryotic Genome Annotation Pipeline (PGAP) Reference genome RefSeq Source Type: news

Md. life sciences firm recalls a product linked to infections amid a new patient lawsuit
Some patients who received the bone repair product said they suffered post-surgical infections, including tuberculosis. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 23, 2021 Category: American Health Authors: Sara Gilgore Source Type: news

Common antibiotic found useful in accelerating recovery in tuberculosis patients
(National University of Singapore, Yong Loo Lin School of Medicine) Researchers from NUS Yong Loo Lin School of Medicine's Infectious Diseases Translational Research Programme have discovered that the use of a common antibiotic, doxycycline, in combination with TB drug treatment, reduces the size of lung cavities and accelerates markers of lung recovery. This was done in a trial with 30 pulmonary tberculosis patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 19, 2021 Category: Infectious Diseases Source Type: news

TB Outbreak May Be Linked to Bone Repair Product
FRIDAY, June 18, 2021 -- A tuberculosis outbreak that may be linked to a product used to repair bones is being investigated by U.S. health officials. More than 100 patients may have been infected after having spinal surgery or fracture repairs with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 18, 2021 Category: Pharmaceuticals Source Type: news

Nigeria: Global Fund Provides U.S.$900 Million for Anti-Malaria, Tuberculosis Intervention in Nigeria
[This Day] Global has allocated the sum of $900 million to support national efforts to address the challenges of malaria, tuberculosis and HIV in Nigeria. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 17, 2021 Category: Infectious Diseases Source Type: news

Study validates a highly sensitive molecular test to detect cases of Tubercul
(Barcelona Institute for Global Health (ISGlobal)) The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 17, 2021 Category: Infectious Diseases Source Type: news

Stem cells may hold a key to developing new vaccines against COVID-19
(Elsevier) The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice. This knowledge may help to develop new vaccines for COVID-19 and avoid a potential global tuberculosis epidemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 16, 2021 Category: Infectious Diseases Source Type: news

South Africa: TB Still SA's Leading Cause of Death
[SAnews.gov.za] A Statistics South Africa (Stats SA) report has revealed that Tuberculosis remained the main leading cause of death in South Africa between 2016 and 2018. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 15, 2021 Category: Infectious Diseases Source Type: news

New studies identify how tuberculosis destroy the lungs and how to protect them
(University of Southampton) A " 3D Culture System " developed by University of Southampton has closely replicated how cells infected with TB change in the human lung. Analytical evidence of these changes identified 7 key gene changes that cause damage in the lungs, from hundreds of thousands. A second trial showed that a common antibiotic, doxycycline, could help reverse these changes and speed up recovery. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2021 Category: Infectious Diseases Source Type: news